Clinuvel Pharmaceuticals | CUV - Ebitda

Aktienkurs
9.14
Täglich Wechseln
-0.10 -1.03%
Monatlich
-5.43%
Jährlich
-13.74%
Q2 Prognose
8.91




Ebitda Veränderung Datum
Avita Medical AUD -9.69M 12.21M 2025-12
Medical Developments International AUD 1.78M 3.78M 2024-12
Mesoblast USD -20.3M 2.51M 2025-12
Neuren Pharmaceuticals AUD 11.14M 165.56M 2025-12
Pacific Edge NZD -13.97M 332K 2024-09
Paradigm Biopharmaceuticals AUD -5.86M 3.79M 2024-12
PYC Therapeutics AUD -22.79M 1.5M 2025-12
Telix Pharmaceuticals AUD 18.42M 14.82M 2025-12